[1]
K. N. Sobirdjanovna, T. Mirkomil, S. Siyovush, T. Zoyirjon, and O. Dilorom, “Pros and Cons of Using a Combination of Glow-Lowing Drugs, In Particular Dpp-4 Inhibitors and Metformin in Patients with Type 2 Diabetes and Overweight”, JSML, vol. 2, no. 4, pp. 50–53, Apr. 2024.